Clinical trial
Evaluation of EXPAREL for Prolonged Postsurgical Analgesia in Subjects…
NCT02517905 · Pacira Pharmaceuticals, Inc, Industry · Completed
Key facts
| NCT number | NCT02517905 |
|---|---|
| Title | Evaluation of EXPAREL for Prolonged Postsurgical Analgesia in Subjects Undergoing Third Molar Extraction |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Local Administration of EXPAREL for Prolonged Postsurgical Analgesia in Subjects Undergoing Third Molar Extraction |
| Lead sponsor | Pacira Pharmaceuticals, Inc, Industry |
| Collaborators | Lotus Clinical Research, LLC |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dental Pain |
| Intervention type | Drug |
| Interventions | Bupivacaine liposome, Placebo |
| Enrollment | 166 |
| Start date | Aug 1, 2015 |
| Primary completion | Jan 1, 2016 |
| Completion | Jan 1, 2016 |
| First posted | Aug 7, 2015 |
| Last update posted | Dec 10, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: